Browsing by Author "Riel, P.L.C.M. van"

Now showing items 1-50 of 455

Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss
Parsons, C.M.; Judge, A.; Leyland, K.; Bruyere, O.; Dop, F. Petit; Chapurlat, R.; Reginster, J.Y.; Edwards, M.H.; Dennison, E.M.; Riel, P.L.C.M. van ; Cooper, C.; Inskip, H. et al. sine al.
2019, Article / Letter to editor (Arthritis Care & Research, vol. 71, iss. 2, (2019), pp. 300-307)
Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases
Acosta-Herrera, M.; Kerick, M.; Gonzalez-Serna, D.; Wijmenga, C.; Franke, A.; Gregersen, P.K.; Padyukov, L.; Worthington, J.; Vyse, T.J.; Alarcon-Riquelme, M.E.; Vonk, M.C. ; Riel, P.L.C.M. van ; Broen, J.C.A.; Coenen, M.J.H. ; Radstake, T.R. ; Mayes, M.D.; Martin, J. et al. sine al.
2019, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 78, iss. 3, (2019), pp. 311-319)
Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity
Lamers-Karnebeek, F.B.G.; Jacobs, Johannes W. G.; Radstake, T.R.D.J. ; Riel, P.L.C.M. van ; Jansen, Tim L.
2019, Article / Letter to editor (Rheumatology, vol. 58, iss. 3, (2019), pp. 427-431)
Patient Self-Management and Tracking A European Experience
Riel, P.L.C.M. van ; Zuidema, R.M.; Vogel, Carine; Rongen-van Dartel, S.A.A.
2019, Article / Letter to editor (Rheumatic Disease Clinics of North America, vol. 45, iss. 2, (2019), pp. 187-195)
Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39
Spiliopoulou, Athina; Colombo, M.; Plant, Darren; Nair, Nisha; Cui, Jing; Coenen, M.J.H. ; Riel, P.L.C.M. van ; Barton, Anne; McKeigue, Paul
2019, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 78, iss. 8, (2019), pp. 1055-1061)
Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment
Moghadam, M. Ghiti; Lamers-Karnebeek, F.B.G.; Vonkeman, H.E.; Klooster, P.M. ten; Tekstra, J.; Schaeybroeck, B. van; Klaasen, R.; Onna, M. van; Moens, H.J.; Visser, H.; Schilder, A.M.; Kok, M.R.; Landewe, R.B.; Riel, P. van ; Laar, M. van de; Jansen, T.L et al. sine al.
2019, Article / Letter to editor (BMC Rheumatology, vol. 3, (2019), article 22)
Development of an item bank to measure factual disease and treatment related knowledge of rheumatoid arthritis patients in the treat to target era
Jonge, M.J. de ; Voshaar, Martijn A.H.Oude; Huis, A.M.P. ; Laar, Mart A. F. J. van de; Hulscher, M.E.J.L. ; Riel, P.L.C.M. van
2018, Article / Letter to editor (Patient Education and Counseling, vol. 101, iss. 1, (2018), pp. 67-73)
Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease
Moghadam, M. Ghiti; Klooster, P.M. ten; Vonkeman, H.E.; Kneepkens, E.L.; Klaasen, R.; Stolk, J.N.; Tchetverikov, I.; Vreugdenhil, S.A.; Woerkom, J.M. van; Goekoop-Ruiterman, Y.P.M.; Landewe, R.B.; Riel, P. van ; Laar, M. van de; Jansen, T.L et al. sine al.
2018, Article / Letter to editor (Arthritis Care & Research, vol. 70, iss. 4, (2018), pp. 516-524)
Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care
Weijers, J.M.; Rongen-van Dartel, S.A.A.; Hoevenaars, D.; Rubens, M.; Hulscher, M.E.J.L. ; Riel, P.L.C.M. van
2018, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 77, iss. 4, (2018), pp. 480-483)
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis
Radner, Helga; Chatzidionysiou, K.; Nikiphorou, E.; Gossec, L.; Hyrich, K.L.; Zabalan, Condruta; Riel, P.L. van ; Dixon, W.G.; Askling, J.
2018, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 77, iss. 4, (2018), pp. 476-479)
Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment
Moghadam, Marjan Ghiti; Lamers-Karnebeek, F.B.G.; Vonkeman, H.E.; Klooster, P.M. ten; Tekstra, J.; Schilder, A.M.; Riel, P.L.C.M. van ; Laar, Mart A. F. J. van de; Jansen, Tim L.
2018, Article / Letter to editor (PLoS One, vol. 13, iss. 5, (2018), article e0192425)
Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis
Crowson, Cynthia S.; Rollefstad, Silvia; Ikdahl, Eirik; Kitas, George D.; Riel, P.L.C.M. van ; Gabriel, Sherine E.; Arts, E.E.A.; Meek, I.L.; Samb, Anne Grete
2018, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 77, iss. 1, (2018), pp. 48-54)
An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label Trial
Tran-Duy, A.; Ghiti Moghadam, M.; Oude Voshaar, M.A.H.; Vonkeman, H.E.; Boonen, A.; Clarke, P.; McColl, G.; Klooster, P.M. ten; Zijlstra, T.R.; Lems, W.F.; Riyazi, N.; Griep, E.N.; Hazes, J.M.; Landewe, R.; Moens, H.J.; Riel, P. van ; Laar, M. van de; Jansen, T.L et al. sine al.
2018, Article / Letter to editor (Arthritis & Rheumatology, vol. 70, iss. 10, (2018), pp. 1557-1564)
Comparison of the construct validity and reproducibility of four different types of patient-reported outcome measures (PROMs) in patients with rheumatoid arthritis
Renskers, L.; Uden, Ron J.J.C. van; Huis, A.M.P. ; Dartel, S.A.A. van ; Teerenstra, S. ; Riel, P.L.C.M. van
2018, Article / Letter to editor (Clinical Rheumatology, vol. 37, iss. 12, (2018), pp. 3191-3199)
Ultrasound: A Potential Tool for Detecting of Fasciitis in Dermatomyositis and Polymyositis
Bhansing, K.J.; Rosmalen, M.H. Van; Engelen, B.G.M. van ; Riel, P.L. van ; Pillen, S.; Vonk, M.C.
2018, Article / Letter to editor (The Journal of Rheumatology, vol. 45, iss. 3, (2018), pp. 441-442)
Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial
Ferwerda, M.; Beugen, S. van; Middendorp, H. van ; Visser, H.; Vonkeman, H.E.; Creemers, Marjonne; Riel, P. van ; Kievit, W. ; Evers, A.
2018, Article / Letter to editor (Journal of Medical Internet Research, vol. 20, iss. 10, (2018), article e260)
Tailored Therapist-guided Internet-based Cognitive-behavioural Treatment for Psoriasis and Rheumatoid Arthritis: Two Case Reports
Spillekom-van Koulil, S. ; Ferwerda, M.; Beugen, S. van; Middendorp, H. van ; Kerkhof, P.C.M. van de ; Riel, P.L.C.M. van ; Evers, A.W.M.
2018, Article / Letter to editor (Acta Dermato-Venereologica, vol. 98, iss. 2, (2018), pp. 225-233)
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries
Crowson, C.S.; Gabriel, S.E.; Semb, A.G.; Riel, P.L.C.M. van ; Karpouzas, G.; Dessein, P.H.; Hitchon, C.; Pascual-Ramos, V.; Kitas, G.D.
2017, Article / Letter to editor (Rheumatology, vol. 56, iss. 7, (2017), pp. 1102-1110)
Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors
Lamers-Karnebeek, F.B.G.; Luime, J.J.; Cate, D.F. Ten; Teerenstra, S. ; Swen, N.; Gerards, A.H.; Hendrikx, J. ; Rooyen, E.M. van; Voorneman, R.; Haagsma, C.; Basoski, N.; Jager, M. de; Moghadam, M. Ghiti; Efde, M.N.; Goekoop-Ruiterman, Y.P.M.; Riel, P. van ; Jacobs, J.W.G.; Jansen, T.L et al. sine al.
2017, Article / Letter to editor (Rheumatology, vol. 56, iss. 9, (2017), pp. 1560-1565)
Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy
Bhansing, K.J.; Vonk-Noordegraaf, A.; Oosterveer, F.P.; Riel, P.L.C.M. van ; Vonk, M.C.
2017, Article / Letter to editor (Rheumatic & Musculoskeletal Diseases Open, vol. 3, iss. 1, (2017), pp. e000331)
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey
Group, G.-R.; Ramos-Remus, C.; Ramirez-Gomez, A.; Brambila-Barba, V.; Barajas-Ochoa, A.; Castillo-Ortiz, J.D.; Adebajo, A.O.; Espinoza, L.R.; Aceves-Avila, F.J.; Sanchez-Gonzalez, J.M.; Boudersa, N.; Slimani, S.; Ladjouze-Rezig, A.; Diaz, M.P.; Kirmayr, K.I.; Asnal, C.A.; Catoggio, L.J.; Citera, G.; Casado, G.C.; Alvarez, A.P.; Pisoni, C.N.; Benavente, E. Diez; Lopez-Cabanillas, A.; Baez, R.M.; Pons-Estel, B.A.; Sacnun, M.P.; Cavallasca, J.A.; Paniego, R.H.; Proudman, S.M.; Thomas, R.; Major, G.; Mathers, D.M.; Schrieber, L.; Haq, S.A.; Islam, N.; Dessein, P.H.; Muhlen, C.A. Von; Bianchi, W.A.; Castelar-Pinheiro, G. da Rocha; Feldman-Pollak, D.; Cossermelli, W.; Bonfiglioli, K.R.; Giorgi, R.D.; Zabsonre-Tiendrebeogo, W.J.; Russell, A.S.; Olaru, L.; Karsh, J.; Fuentealba, C.; Aguilera, S.; Castro-Esparza, I.H.; Burgos, P.I.; Neira, O.; Li, Z.-G.; Tam, L.-S.; Mok, M.Y.; Medina, Y.F.; Moreno-Alvarez, M.J.; Zuniga-Vera, A.E.; Vera, C.; Quezada, I.; Moreno, I.M.; Calapaqui, W.; El-Mardenly, G.; Salama, M.S.; Ragab, G.; Hadidi, T.; Gado, K.; Leirisalo-Repo, M.; Tuompo, R.; Koivuniemi, R.; Berenbaum, F.; Allanore, Y.; Constantin, A.; Buttgereit, F.; Schulze-Koops, H.; Liz, M.; Dey, D.; Alonzo-Borjas, H.D.; Santiago-Pastelin, C.B.; Cuellar-Cruz, V.; Dharmanand, B.G.; Yathish, G.C.; Akerkar, S.M.; Malaviya, A.N.; Ahmadzadeh, A.; Hasunuma, T.; Owino, B.O.; Pacheco-Tena, C.; Frausto-Arenas, A.; Madrid-Cernas, A.A. De la; Cardona-Cabrera, R.; Centeno-Valadez, J.D.; Rodriguez-Torres, I.M.; Vaidya, B.; Gupta, A.K.; Harrison, A.A.; Grainger, R.; Nwankwo, H.M.; Diamantopoulos, A.P.; Maland, E., et al.; Jansen, T.L.; Riel, P. van ; Nunez-Sotelo, C.M.; Villegas-Morales, S. et al. sine al.
2017, Article / Letter to editor (Clinical Rheumatology, vol. 36, iss. 3, (2017), pp. 485-497)
A pilot study of CXCL8 levels in crystal proven gout patients during allopurinol treatment and their association with cardiovascular disease
Kienhorst, L.; Janssens, H. ; Radstake, T.R. ; Riel, P. van ; Jacobs, J.; Koolwijk, E. van; Lochem, E. van
2017, Article / Letter to editor (Joint Bone Spine, vol. 84, iss. 6, (2017), pp. 709-713)
The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength
Worm-Smeitink, M.G.; Gielissen, M.F. ; Bloot, L.; Laarhoven, H.W.M. van ; Engelen, B.G.M. van ; Riel, P. van ; Bleijenberg, G. ; Nikolaus, S.; Knoop, H.
2017, Article / Letter to editor (Journal of Psychosomatic Research, vol. 98, (2017), pp. 40-46)
The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey
Nikiphorou, E.; Galloway, J.; Riel, P. van ; Yazici, Y.; Haugeberg, G.; Ostor, A.; Gogus, F.; Kauppi, M.; Sokka, T.
2017, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 35, iss. 3, (2017), pp. 477-483)
Low disease activity (DAS28</=3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study
Arts, E.E.A.; Fransen, J. ; Broeder, A.A. den; Riel, P. van ; Popa, C.
2017, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 76, iss. 10, (2017), pp. 1693-1699)
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
Crowson, C.S.; Rollefstad, S.; Kitas, G.D.; Riel, P.L.C.M. van ; Gabriel, S.E.; Semb, A.G.
2017, Article / Letter to editor (PLoS One, vol. 12, iss. 3, (2017), article e0174656)
Muscle ultrasonography is a potential tool for detecting fasciitis in dermatomyositis and polymyositis: comment on the article by Yoshida et al
Bhansing, K.J.; Rosmalen, M.H. Van; Engelen, B.G.M. van ; Riel, P.L.C.M. van ; Pillen, S. ; Vonk, M.C.
2017, Article / Letter to editor (Arthritis & Rheumatology, vol. 69, iss. 11, (2017), pp. 2248-2249)
Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis
Kievit, W. ; Maurits, J.S.; Arts, E.E.A.; Riel, P.L.C.M. van ; Fransen, J. ; Popa, C.
2017, Article / Letter to editor (Arthritis Care & Research, vol. 69, iss. 2, (2017), pp. 175-182)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Smolen, J.S.; Landewe, R.; Bijlsma, J.; Burmester, G.; Chatzidionysiou, K.; Dougados, M.; Nam, J.; Ramiro, S.; Voshaar, M.; Vollenhoven, R. van; Aletaha, D.; Aringer, M.; Boers, M; Buckley, C.D.; Buttgereit, F.; Bykerk, V.; Cardiel, M.; Combe, B.; Cutolo, M.; Eijk-Hustings, Y. van; Emery, P.; Finckh, A.; Gabay, C.; Gomez-Reino, J.; Gossec, L.; Gottenberg, J.-E.; Hazes, J.M.; Huizinga, T.; Jani, M.; Karateev, D.; Kouloumas, M.; Kvien, T.; Li, Z.; Mariette, X.; McInnes, I.; Mysler, E.; Nash, P.; Pavelka, K.; Poor, G.; Richez, C.; Riel, P. van ; Rubbert-Roth, A.; Saag, K.; Silva, J.; Stamm, T.; Takeuchi, T.; Westhovens, R.; Wit, M. de; Heijde, D. van der et al. sine al.
2017, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 76, iss. 6, (2017), pp. 960-977)
IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis
Damen, M.S.M.A.; Agca, R.; Holewijn, S.; Graaf, J. de ; Santos, J.C. Dos; Riel, P.L.C.M. van ; Fransen, J. ; Coenen, M.J.H. ; Nurmohamed, M.T.; Netea, M.G. ; Dinarello, C.A. ; Joosten, L.A.B. ; Heinhuis, B. ; Popa, C. et al. sine al.
2017, Article / Letter to editor (Scientific Reports, vol. 7, (2017), article 41629)
A tailored-guided internet-based cognitive-behavioral intervention for patients with rheumatoid arthritis as an adjunct to standard rheumatological care: results of a randomized controlled trial
Ferwerda, M.; Beugen, S. van; Middendorp, H. van ; Koulil, S. van ; Donders, A.R.T. ; Visser, H.; Taal, E.; Creemers, M.C.; Riel, P.L.C.M. van ; Evers, A.W.M.
2017, Article / Letter to editor (Pain, vol. 158, iss. 5, (2017), pp. 868-878)
Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
Hendrikx, J. ; Jonge, M.J. de; Fransen, J. ; Kievit, W. ; Riel, P.L.C.M. van
2016, Article / Letter to editor (Rheumatic & Musculoskeletal Diseases Open, vol. 2, iss. 2, (2016), article e000202)
Patients with Systemic Sclerosis/polymyositis Overlap Have a Worse Survival Rate Than Patients Without It
Bhansing, K.J.; Riel, P.L.C.M. van ; Engelen, B.G.M. van ; Fransen, J. ; Vonk, M.C.
2016, Article / Letter to editor (The Journal of Rheumatology, vol. 43, iss. 10, (2016), pp. 1838-1843)
Détection des cristaux d’urate monosodique dans le liquide synovial après stockage de longue durée et dans des conditions variables
Kienhorst, L.B.; Janssens, H.J.E.M. ; Eijgelaar, R.S.; Radstake, T.R.; Riel, P.L.C.M. van ; Janssen, M
2016, Article / Letter to editor (Revue du Rhumatisme, vol. 83, iss. 5, (2016), pp. 396-397)
A different perspective: Inflammatory rheumatic diseases and other organs
Kitas, G.D.; Riel, P.L.C.M. van
2016, Article / Letter to editor (Best Practice & Research Clinical Rheumatology, vol. 30, iss. 5, (2016), pp. 787-788)
High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study
Edwards, M.H.; Parsons, C.; Bruyere, O.; Petit Dop, F.; Chapurlat, R.; Roemer, F.W.; Guermazi, A.; Zaim, S.; Genant, H.; Reginster, J.Y.; Dennison, E.M.; Cooper, C.; Riel, P.L.C.M. van ; et al. et al. sine al.
2016, Article / Letter to editor (The Journal of Rheumatology, vol. 43, iss. 3, (2016), pp. 657-665)
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools
Riel, P. van ; Alten, R.; Combe, B.; Abdulganieva, D.; Bousquet, P.; Courtenay, M.; Curiale, C.; Gomez-Centeno, A.; Haugeberg, G.; Leeb, B.; Puolakka, K.; Ravelli, A.; Rintelen, B.; Sarzi-Puttini, P. et al. sine al.
2016, Article / Letter to editor (Rheumatic & Musculoskeletal Diseases Open, vol. 2, iss. 2, (2016), pp. e000302)
Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use
Mavrogeni, S.I.; Kitas, G.D.; Dimitroulas, T.; Sfikakis, P.P.; Seo, P.; Gabriel, S.; Patel, A.R.; Gargani, L.; Bombardieri, S.; Matucci-Cerinic, M.; Lombardi, M.; Pepe, A.; Aletras, A.H.; Kolovou, G.; Miszalski, T.; Riel, P. van ; Semb, A.; Gonzalez-Gay, M.A.; Dessein, P.; Karpouzas, G.; Puntmann, V.; Nagel, E.; Bratis, K.; Karabela, G.; Stavropoulos, E.; Katsifis, G.; Koutsogeorgopoulou, L.; Rossum, A. van; Rademakers, F.; Pohost, G.; Lima, J.A. et al. sine al.
2016, Article / Letter to editor (International Journal of Cardiology, vol. 217, (2016), pp. 135-148)
Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry
Steunebrink, L.M.; Vonkeman, H.E.; Klooster, P.M. ten; Hoekstra, M.; Riel, P.L.C.M. van ; Laar, M.A. van der
2016, Article / Letter to editor (Clinical Rheumatology, vol. 35, iss. 3, (2016), pp. 609-615)
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study
Gabay, C.; Riek, M.; Hetland, M.L.; Hauge, E.M.; Pavelka, K.; Tomsic, M.; Canhao, H.; Chatzidionysiou, K.; Lukina, G.; Nordstrom, D.C.; Lie, E.; Ancuta, I.; Hernandez, M.V.; Riel, P.L.C.M. van ; Vollenhoven, R. van; Kvien, T.K. et al. sine al.
2016, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 75, iss. 7, (2016), pp. 1336-1342)
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration
Chatzidionysiou, K.; Lie, E.; Nasonov, E.; Lukina, G.; Hetland, M.L.; Tarp, U.; Ancuta, I.; Pavelka, K.; Nordstrom, D.C.; Gabay, C.; Canhao, H.; Tomsic, M.; Riel, P.L. van ; Gomez-Reino, J.; Kvien, T.K.; Vollenhoven, R.F. van et al. sine al.
2016, Article / Letter to editor (Arthritis Research & Therapy, vol. 18, iss. 1, (2016), pp. 50)
Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry
Steunebrink, L.M.; Versteeg, G.A.; Vonkeman, H.E.; Klooster, P.M. ten; Kuper, H.H.; Zijlstra, T.R.; Riel, P.L.C.M. van ; Laar, M.A. van der
2016, Article / Letter to editor (Arthritis Research & Therapy, vol. 18, iss. 1, (2016), pp. 60)
Impaired Porphyromonas gingivalis-Induced Tumor Necrosis Factor Production by Dendritic Cells Typifies Patients With Rheumatoid Arthritis
Santegoets, K.C.M.; Wenink, M.H. ; Braga, F.A.; Cossu, M.; Lamers-Karnebeek, F.B.G.; Riel, P.L.C.M. van ; Sturm, P.D.J. ; Berg, W.B. van den ; Radstake, T.R.D.J.
2016, Article / Letter to editor (Arthritis & Rheumatology, vol. 68, iss. 4, (2016), pp. 795-804)
Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial
Moghadam, M. Ghiti; Vonkeman, H.E.; Klooster, P.M. ten; Tekstra, J.; Schaardenburg, D. van; Starmans-Kool, M.; Brouwer, E.; Bos, R. van den; Lems, W.F.; Colin, E.M.; Allaart, C.F.; Meek, I.L.; Landewe, R.; Moens, H.J.; Riel, P.L.C.M. van ; Laar, M.A. van der; Jansen, T.L.Th.A. et al. sine al.
2016, Article / Letter to editor (Arthritis & Rheumatology, vol. 68, iss. 8, (2016), pp. 1810-1817)
The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis
Riel, P.L.C.M. van ; Renskers, L.
2016, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 34 Suppl 1, iss. 5, (2016), pp. 40-44)
Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms
Arts, E.E.A.; Popa, C. ; Broeder, A.A. den; Donders, R. ; Sandoo, A.; Toms, T.; Rollefstad, S.; Ikdahl, E.; Semb, A.G.; Kitas, G.D.; Riel, P.L.C.M. van ; Fransen, J. et al. sine al.
2016, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 75, iss. 4, (2016), pp. 674-680)
A multidimensional 'path analysis' model of factors explaining fatigue in rheumatoid arthritis
Dartel, S.A.A. van ; Repping-Wuts, H. ; Donders, R. ; Hoogmoed, D. van ; Knoop, H. ; Bleijenberg, G. ; Riel, P.L.C.M. van ; Fransen, J.
2016, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 34, iss. 2, (2016), pp. 200-206)
Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry
Manders, S.H.; Kievit, W. ; Jansen, T.L.; Stolk, J.N.; Visser, H.; Schilder, A.M.; Vonkeman, H.E.; Adang, E.M. ; Laar, M.A.F.J. van de; Riel, P.L.C.M. van
2016, Article / Letter to editor (The Journal of Rheumatology, vol. 43, iss. 10, (2016), pp. 1787-1794)
The influence of patient perceptions of disease on medication intensification in daily practice
Hendrikx, J. ; Kievit, W. ; Fransen, J. ; Riel, P.L.C.M. van
2016, Article / Letter to editor (Rheumatology, vol. 55, iss. 11, (2016), pp. 1938-1945)
Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment
Reek, J.M. van den; Pijls, P.A.; Tummers, M.J.G.M. ; Riel, P.L.C. van ; Kievit, W. ; Hoentjen, F.; Jong, E.M.G.J. de
2016, Article / Letter to editor (Journal of the American Academy of Dermatology, vol. 74, iss. 1, (2016), pp. 177-179)

Now showing items 1-50 of 455

Radboud Repository

Browsing by Author "Riel, P.L.C.M. van"

Search Repository

Browse

All of Repository